Literature DB >> 2617360

Experimental analysis of the spinal cord compressed by spinal metastasis.

S Manabe1, H Tanaka, Y Higo, P Park, T Ohno, A Tateishi.   

Abstract

The purpose of the present study of experimental spinal metastasis, developed in rats by inoculation of tumor cells through the spinous process, was to find the factor that causes the initial damage to the cord in this disorder. In the early stage of paralysis, the degenerated posterior funiculus originated from a small hemorrhagic area in the posterior column of the involved cord. Using the scanning electron microscope, the hemorrhage was found to be from the intrinsic vein, resulting from the disturbance of venous drainage in the compressed portion. In the early stage of compression, extravasation of horseradish peroxidase was observed in the white matter, but histologic degeneration was not. A hemorrhage existed wherever degeneration of the funiculus was observed. Therefore, the trigger to induce the initial damage on the cord in spinal metastasis was not likely to be vasogenic edema, but instead the intrinsic venous hemorrhage.

Entities:  

Mesh:

Year:  1989        PMID: 2617360     DOI: 10.1097/00007632-198912000-00007

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  10 in total

1.  Metastatic spinal cord compression in non-small cell lung cancer patients. Prognostic factors in a series of 356 patients.

Authors:  D Rades; S Douglas; T Veninga; A Bajrovic; L J A Stalpers; P J Hoskin; V Rudat; S E Schild
Journal:  Strahlenther Onkol       Date:  2012-02-25       Impact factor: 3.621

2.  [Not Available].

Authors:  B W Böttiger
Journal:  Med Klin Intensivmed Notfmed       Date:  2016-03       Impact factor: 0.840

3.  Do elderly patients benefit from surgery in addition to radiotherapy for treatment of metastatic spinal cord compression?

Authors:  D Rades; S Huttenlocher; J N Evers; A Bajrovic; J H Karstens; V Rudat; S E Schild
Journal:  Strahlenther Onkol       Date:  2012-02-16       Impact factor: 3.621

Review 4.  The role of radiotherapy for metastatic epidural spinal cord compression.

Authors:  Dirk Rades; Janet L Abrahm
Journal:  Nat Rev Clin Oncol       Date:  2010-08-31       Impact factor: 66.675

5.  Prognostic factors in a series of 504 breast cancer patients with metastatic spinal cord compression.

Authors:  D Rades; S Douglas; T Veninga; L J A Stalpers; A Bajrovic; V Rudat; S E Schild
Journal:  Strahlenther Onkol       Date:  2012-02-23       Impact factor: 3.621

6.  Prognostic factors and a survival score for patients with metastatic spinal cord compression from colorectal cancer.

Authors:  D Rades; S Douglas; S Huttenlocher; T Veninga; A Bajrovic; V Rudat; S E Schild
Journal:  Strahlenther Onkol       Date:  2012-11-01       Impact factor: 3.621

7.  Prognostic factors for different outcomes in patients with metastatic spinal cord compression from cancer of unknown primary.

Authors:  Sarah Douglas; Stefan Huttenlocher; Amira Bajrovic; Volker Rudat; Steven E Schild; Dirk Rades
Journal:  BMC Cancer       Date:  2012-06-21       Impact factor: 4.430

8.  A matched-pair analysis comparing 5x4 Gy and 10x3 Gy for metastatic spinal cord compression (MSCC) in patients with favorable survival prognoses.

Authors:  Dirk Rades; Stefan Huttenlocher; Theo Veninga; Amira Bajrovic; Michael Bremer; Volker Rudat; Steven E Schild
Journal:  Radiat Oncol       Date:  2015-04-15       Impact factor: 3.481

9.  Delayed neurological deterioration after surgery for intraspinal meningiomas: Ischemia-reperfusion injury in a rat model.

Authors:  Liang Wu; Tao Yang; Chenlong Yang; Ning Yao; Huiliang Wang; Jingyi Fang; Yulun Xu
Journal:  Oncol Lett       Date:  2015-08-19       Impact factor: 2.967

Review 10.  Prognostic Factors for Bone Survival and Functional Outcomes in Patients With Breast Cancer Spine Metastases.

Authors:  Rui-Qi Qiao; Hao-Ran Zhang; Rong-Xing Ma; Rui-Feng Li; Yong-Cheng Hu
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.